OBJECTIVE: Insulin lispro is a rapid-acting analog of human insulin that can be used to target the postprandial rise in plasma glucose. We designed an open-label randomized crossover study of type 2 diabetic patients with secondary failure of sulfonylurea therapy to determine whether improvement of postprandial hyperglycemia would affect total daily glucose control. RESEARCH DESIGN AND METHODS: Twenty-five type 2 diabetic patients who were poorly controlled on a maximum dose of sulfonylureas ...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.
If you are the owner of this record, you can report an update to it here: Report update to this record